$Oracle(ORCL)$ Most of the share-price decline caused by that $3 billion headline will likely be recovered in after-hours or tomorrow. Oracle's problem isn't a lack of demand or an inability to sell its products—it's the exact opposite. The company is struggling to keep up with a backlog that has already exceeded $600 billion. Demand remains far ahead of available capacity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
